MEI PHARMA INC (MEIP) Stock Analyst Ratings
USA - NASDAQ:MEIP - US55279B3015 - Common Stock
3.07 USD
+0.29 (+10.43%)
3.16 USD
+0.09 (+2.93%)
ChartMill assigns a Buy % Consensus number of 43% to MEIP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 99.35% above the current price.
MEIP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MEIP.
In the previous month the buy percentage consensus was at a similar level.
MEIP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-23 | Laidlaw & Co. | Downgrade | Buy -> Hold |
| 2024-04-12 | Stifel | Maintains | Hold -> Hold |
| 2024-02-14 | Stifel | Maintains | Hold -> Hold |
| 2023-09-27 | Stifel | Maintains | Hold -> Hold |
| 2023-05-23 | Brookline Capital | Maintains | Buy -> Buy |
| 2023-05-12 | Stifel | Maintains | Hold -> Hold |
| 2023-02-13 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-12-06 | BTIG | Downgrade | Buy -> Neutral |
| 2022-12-06 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-02-03 | Jefferies | Initiate | Buy |
MEI PHARMA INC / MEIP FAQ
What is the price target for MEIP stock?
6 analysts have analysed MEIP and the average price target is 6.12 USD. This implies a price increase of 99.35% is expected in the next year compared to the current price of 3.07.
What is the consensus rating for MEIP stock?
The consensus rating for MEI PHARMA INC (MEIP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.